Your browser is no longer supported. Please, upgrade your browser.
Settings
NUVA NuVasive, Inc. daily Stock Chart
NUVA [NASD]
NuVasive, Inc.
Index- P/E138.58 EPS (ttm)0.41 Insider Own0.30% Shs Outstand51.37M Perf Week6.02%
Market Cap2.91B Forward P/E20.26 EPS next Y2.80 Insider Trans8.44% Shs Float50.87M Perf Month14.46%
Income23.60M PEG9.78 EPS next Q0.58 Inst Own- Short Float9.06% Perf Quarter10.27%
Sales1.04B P/S2.80 EPS this Y67.50% Inst Trans-0.30% Short Ratio6.94 Perf Half Y-6.24%
Book/sh14.88 P/B3.81 EPS next Y14.49% ROA2.60% Target Price59.56 Perf Year-26.91%
Cash/sh- P/C- EPS next 5Y14.17% ROE5.70% 52W Range44.62 - 81.68 Perf YTD-3.09%
Dividend- P/FCF25.43 EPS past 5Y74.50% ROI7.30% 52W High-30.61% Beta0.43
Dividend %- Quick Ratio1.30 Sales past 5Y10.70% Gross Margin73.00% 52W Low27.03% ATR1.18
Employees2400 Current Ratio2.40 Sales Q/Q4.60% Oper. Margin6.90% RSI (14)74.28 Volatility2.43% 2.20%
OptionableYes Debt/Eq0.84 EPS Q/Q-346.30% Profit Margin4.10% Rel Volume0.74 Prev Close55.87
ShortableYes LT Debt/Eq0.77 EarningsJul 31 AMC Payout0.00% Avg Volume664.46K Price56.68
Recom2.40 SMA208.20% SMA509.01% SMA2005.52% Volume512,186 Change1.45%
Jun-01-18Initiated Cantor Fitzgerald Neutral
May-02-18Reiterated Needham Buy $70 → $69
Apr-04-18Initiated Goldman Neutral $47
Feb-27-18Reiterated Needham Buy $71 → $70
Feb-01-18Downgrade Leerink Partners Outperform → Mkt Perform
Jan-17-18Downgrade Wells Fargo Outperform → Market Perform
Jan-04-18Upgrade Needham Underperform → Buy $71
Nov-10-17Reiterated RBC Capital Mkts Outperform $75 → $70
Oct-25-17Reiterated Canaccord Genuity Buy $75 → $70
Sep-07-17Initiated BTIG Research Buy $82
Aug-28-17Downgrade Needham Hold → Underperform
Jul-28-17Downgrade Robert W. Baird Outperform → Neutral $79 → $72
Jun-06-17Reiterated RBC Capital Mkts Outperform $76 → $85
Nov-30-16Initiated Aegis Capital Buy $72
Jul-27-16Reiterated Barclays Overweight $63 → $71
Jul-13-16Upgrade JP Morgan Neutral → Overweight $55 → $74
May-27-16Upgrade Barclays Equal Weight → Overweight $58 → $63
Dec-11-15Upgrade BofA/Merrill Underperform → Neutral
Oct-06-15Upgrade Canaccord Genuity Hold → Buy $52 → $58
Sep-14-15Initiated Morgan Stanley Equal-Weight $60
Jun-20-18 08:30AM  First Porous PEEK Spinal Implant Clinical Study Validates NuVasive Advanced Materials Science Technology In Treating Degenerative Cervical Disc Disease PR Newswire
Jun-15-18 08:30AM  Recent Analysis Shows NuVasive, Ecolab, Roku, Northern Trust, Sea Limited, and Twenty-First Century Fox Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Jun-12-18 08:30AM  NuVasive Launches AttraX Scaffold Biologic And Reports First Clinical Use PR Newswire
Jun-11-18 08:30AM  NuVasive Announces Key Finance Appointments PR Newswire
Jun-05-18 04:02PM  NuVasive To Present At The Goldman Sachs Annual Global Healthcare Conference PR Newswire
10:12AM  NuVasive's (NUVA) Global Prospects Solid, Competition Rife Zacks
May-31-18 11:30AM  Kuros Biosciences to Propose Appointment of New Board Members at AGM GlobeNewswire
09:11AM  Why is NuVasive (NUVA) Down 5.7% Since its Last Earnings Report? Zacks
07:20AM  Breakfast Technical Briefing on NovoCure and Three Other Additional Medical Equipment Stocks ACCESSWIRE
May-29-18 08:42AM  Arcturus Therapeutics Appoints Four New Directors and Reaches Settlement Agreement with Founder Joseph E. Payne GlobeNewswire
May-23-18 08:30AM  Nuvasive SpineTRACK Registry Reaches Significant Enrollment Milestone Of 10,000 Patients PR Newswire
May-22-18 08:30AM  NuVasive PRECICE STRYDE System Used In First Patient For Stature Lengthening By International Limb Lengthening Expert PR Newswire
May-16-18 04:02PM  Edited Transcript of NUVA earnings conference call or presentation 1-May-18 8:30pm GMT Thomson Reuters StreetEvents
04:02PM  NuVasive Sponsors SOLAS 2018, Hosts Workshop On Latest Lateral Innovations PR Newswire
May-09-18 04:02PM  NuVasive To Present At The Bank of America Merrill Lynch 2018 Healthcare Conference PR Newswire
May-08-18 04:02PM  NuVasive Unveils Newest Additions To Early Onset Scoliosis Portfolio At POSNA Annual Meeting PR Newswire
May-02-18 08:33AM  NuVasive (NUVA) Q1 Earnings Miss Estimates, Revenues In Line Zacks -9.39%
May-01-18 04:14PM  NuVasive: 1Q Earnings Snapshot Associated Press
04:02PM  NuVasive Announces First Quarter 2018 Financial Results PR Newswire
Apr-24-18 04:02PM  NuVasive Sponsors AANS 2018, Hosts Workshops And Presentations On Latest Innovations PR Newswire
Apr-19-18 07:30AM  New Research: Key Drivers of Growth for NuVasive, Apptio, Apollo Investment, Uranium Energy, AECOM, and US Foods Holding Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Apr-10-18 04:02PM  NuVasive Announces Conference Call And Webcast Of First Quarter 2018 Results PR Newswire
Apr-05-18 04:02PM  NuVasive Sponsors ISASS 2018, Hosts Workshops And Presentations PR Newswire
Apr-02-18 04:02PM  NuVasive Portfolio Now Includes ALIF Retractor Platform For Lateral And Supine Approaches PR Newswire
Mar-29-18 04:02PM  Research Shows NuVasive Porous PEEK Structure Maintains High Porosity After Impaction PR Newswire
Mar-28-18 10:31AM  Why Is NuVasive (NUVA) Up 4.6% Since Its Last Earnings Report? Zacks
Mar-19-18 10:30AM  Orthopedic Device Market Gains Momentum: 3 Stocks in Focus Zacks
Mar-07-18 10:21AM  NuVasive Gains From International Business Amid Pricing Woes Zacks
Mar-05-18 04:02PM  NuVasive to Participate in Investor Events in March 2018 PR Newswire
Feb-28-18 07:52AM  Edited Transcript of NUVA earnings conference call or presentation 26-Feb-18 9:30pm GMT Thomson Reuters StreetEvents
Feb-27-18 10:05AM  NuVasive (NUVA) Meets Q4 Earnings Estimates, Issues '18 View Zacks
Feb-26-18 05:45PM  NuVasive Sees a Stronger 2018 Motley Fool
04:39PM  NuVasive meets 4Q profit forecasts Associated Press
04:02PM  NuVasive Reports Fourth Quarter and Full Year 2017 Financial Results PR Newswire
12:15PM  NuVasive, Inc. to Host Earnings Call ACCESSWIRE
07:33AM  Does NuVasive Incs (NASDAQ:NUVA) Recent Track Record Look Strong? Simply Wall St.
Feb-22-18 10:36AM  International Business Aids NuVasive, Pricing Woe Remains Zacks
Feb-21-18 11:25AM  NuVasive's SpineTRACK Registry Gains New CMS Designation Zacks
Feb-20-18 04:05PM  NuVasive SpineTRACK Registry Named Qualified Clinical Data Registry By Centers Of Medicare And Medicaid Services PR Newswire
Feb-09-18 07:35AM  Research Report Identifies Ichor, TASER International, Premier, NuVasive, Verastem, and BLACKLINE INC with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Feb-08-18 04:05PM  John DeFord To Join NuVasive Board Of Directors PR Newswire
Feb-07-18 04:02PM  Nuvasive Announces Conference Call And Webcast Of Fourth Quarter And Full Year 2017 Results PR Newswire
Jan-12-18 09:45AM  Why Mizuho Securities Upgraded Teva Pharmaceutical to a Buy Market Realist
Jan-10-18 09:22AM  NuVasive Q4 Preliminary Results Fail to Cheer Investors Zacks
Jan-08-18 02:26PM  Here's What Pressured NuVasive, Inc. Stock Today Motley Fool -8.93%
08:30AM  NuVasive Announces Preliminary Unaudited Full Year 2017 Revenue Results And Preliminary 2018 Outlook PR Newswire
Jan-04-18 04:31PM  Medtech Player Bounds On Upgrade Amid Tax Reform, Acquisitions Investor's Business Daily
08:30AM  NuVasive Extends First-Of-Its-Kind Porous PEEK Interbody To TLIF And PLIF Procedures PR Newswire
Jan-03-18 04:02PM  NuVasive To Present At The 36th Annual J.P. Morgan Healthcare Conference PR Newswire
Jan-01-18 08:06AM  See what the IHS Markit Score report has to say about NuVasive Inc. Markit
Dec-28-17 12:31PM  ETFs with exposure to NuVasive, Inc. : December 28, 2017 Capital Cube
Dec-21-17 01:46PM  Medical device maker says savings from new tax law to fuel innovation and growth American City Business Journals
08:30AM  NuVasive Comments On Expected Impact Of U.S. Tax Reform PR Newswire
08:07AM  See what the IHS Markit Score report has to say about NuVasive Inc. Markit
Dec-20-17 08:46AM  NuVasive (NUVA) Global Prospects Solid, Pricing Woes Remain Zacks
Dec-14-17 04:02PM  NuVasive Appoints Experienced Spine Executive Michael Piccirillo To Lead New Global Surgeon Education Platform PR Newswire
07:50AM  NuVasive (NUVA) to Acquire SafePassage, Strengthens IONM Zacks
Dec-12-17 04:02PM  NuVasive To Acquire SafePassage PR Newswire
Dec-08-17 08:07AM  See what the IHS Markit Score report has to say about NuVasive Inc. Markit
Nov-30-17 08:06AM  See what the IHS Markit Score report has to say about NuVasive Inc. Markit
Nov-29-17 08:07AM  See what the IHS Markit Score report has to say about NuVasive Inc. Markit
Nov-27-17 08:06AM  See what the IHS Markit Score report has to say about NuVasive Inc. Markit
Nov-22-17 08:06AM  See what the IHS Markit Score report has to say about NuVasive Inc. Markit
Nov-20-17 12:54PM  5 Lesser-Known Rule Breakers: Where We Stand at the 2-Year Mark Motley Fool
08:06AM  See what the IHS Markit Score report has to say about NuVasive Inc. Markit
07:55AM  Research Report Identifies Hill-Rom, TASER International, Synchronoss Technologies, NuVasive, Verastem, and Roku with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Nov-17-17 08:08AM  See what the IHS Markit Score report has to say about NuVasive Inc. Markit
Nov-16-17 08:30AM  NuVasive To Participate In The 29th Annual Piper Jaffray Healthcare Conference PR Newswire
07:31AM  NuVasive, Inc. breached its 50 day moving average in a Bearish Manner : NUVA-US : November 16, 2017 Capital Cube
Nov-15-17 11:35PM  5 Supernova Stocks That Have Flown Under the Radar: NuVasive Motley Fool
08:06AM  See what the IHS Markit Score report has to say about NuVasive Inc. Markit
Nov-08-17 07:10AM  Earnings Review and Free Research Report: NuVasives Q3 Non-GAAP EPS Surged 30% Y-o-Y; Surprised Expectations ACCESSWIRE
Nov-06-17 12:12PM  ETFs with exposure to NuVasive, Inc. : November 6, 2017 Capital Cube
07:18AM  NuVasive, Inc. breached its 50 day moving average in a Bullish Manner : NUVA-US : November 6, 2017 Capital Cube
Oct-31-17 03:33PM  Glancy Prongay & Murray LLP Commences Investigation on Behalf of NuVasive, Inc. Investors (NUVA) Business Wire
08:05AM  See what the IHS Markit Score report has to say about NuVasive Inc. Markit
Oct-30-17 08:06AM  See what the IHS Markit Score report has to say about NuVasive Inc. Markit
Oct-27-17 11:07AM  ETFs with exposure to NuVasive, Inc. : October 27, 2017 Capital Cube
08:07AM  See what the IHS Markit Score report has to say about NuVasive Inc. Markit
Oct-26-17 09:02AM  NuVasive, Inc. :NUVA-US: Earnings Analysis: Q3, 2017 By the Numbers : October 26, 2017 Capital Cube
08:43AM  NuVasive (NUVA) in Focus: Stock Moves 8.4% Higher Zacks
08:11AM  New Strong Sell Stocks for October 26th Zacks
08:04AM  NuVasive, Inc. breached its 50 day moving average in a Bullish Manner : NUVA-US : October 26, 2017 Capital Cube
Oct-25-17 04:30PM  Why Akamai Technologies, NuVasive, and MacroGenics Jumped Today Motley Fool +8.37%
04:03PM  Here's Why NuVasive, Inc. Popped Today Motley Fool
10:01AM  NuVasive (NUVA) Q3 Earnings Top, Revenues Lag, Guidance Cut Zacks
08:30AM  NuVasive Unveils Latest Innovation At NASS 2017 PR Newswire
06:05AM  Edited Transcript of NUVA earnings conference call or presentation 24-Oct-17 8:30pm GMT Thomson Reuters StreetEvents
Oct-24-17 07:19PM  NuVasive's Sluggish Sales Growth Prompts Buybacks Motley Fool
05:33PM  NuVasive beats 3Q profit forecasts Associated Press
04:04PM  NuVasive Announces $100 Million Share Repurchase Program PR Newswire
04:02PM  NuVasive Reports Third Quarter 2017 Financial Results PR Newswire
09:10AM  NuVasive, Inc. to Host Earnings Call ACCESSWIRE
Oct-23-17 08:30AM  NuVasive Extends Its Leadership As Lateral Spine Technology Innovator With New Lateral Single-Position Surgery Procedure PR Newswire
Oct-22-17 10:00AM  5 Stocks That Look Good Short TheStreet.com
Oct-19-17 09:59AM  NuVasive's TLX Interbody System Gets Expanded FDA Approval Zacks
Oct-18-17 04:05PM  NuVasive Launches New 3D-Printed Porous Titanium Implant In Expanding Advanced Materials Science Portfolio PR Newswire
Oct-17-17 08:05AM  See what the IHS Markit Score report has to say about NuVasive Inc. Markit
Oct-16-17 08:30AM  NuVasive Receives Expanded FDA 510(k) Clearance For TLX Interbody System Used In TLIF Procedures PR Newswire
Oct-13-17 09:03AM  NuVasive's (NUVA) PRECICE System Gets Expanded FDA Approval Zacks
NuVasive, Inc., a medical device company, develops and markets minimally-disruptive surgical products and procedurally-integrated solutions for spine surgery. Its products focus on applications for spine fusion surgery, including ancillary products and services used to aid in the surgical procedure. The company's principal product is Maximum Access Surgery, a minimally-disruptive surgical platform, which includes its software-driven nerve detection and avoidance systems, and intraoperative monitoring (IOM) services and support; MaXcess, an integrated split-blade retractor system; and various specialized implants and biologics. Its spine surgery product line offerings comprise products for the thoracolumbar and the cervical spine, which are primarily used to enable surgeons to access the spine and to perform restorative and fusion procedures in a minimally-disruptive fashion. Its biologics products include Osteocel Plus and Pro, a cellular bone matrix; Formagraft, a collagen-based synthetic bone substitute; AttraX, a synthetic bone graft material; and Propel DBM, a moldable demineralized bone matrix putty, which are used for spinal fusion or bone healing process. The company's IOM services are used for onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. It also provides implants used for interbody disc height restoration; and fixation products, including pedicle screws, rods, and plates. In addition, the company offers Integrated Global Alignment platform for assessing, preserving, and restoring spinal alignment; MAGEC-early onset scoliosis, a spinal bracing and distraction system; and PRECICE, a limb lengthening system. NuVasive, Inc. sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly-employed sales personnel, and distributors in the United States and internationally. The company was founded in 1997 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
OHALLERAN MICHAEL DDirectorMay 18Option Exercise0.002,130012,425May 22 05:57 PM
FARRELL PETER CDirectorMay 03Option Exercise10.3622,844236,70041,490May 07 05:59 PM
HOWE LESLEY HDirectorMay 03Option Exercise0.0015,247026,244May 07 05:57 PM
Rozow StephenEVP, Global ProcessMay 01Option Exercise0.001,68004,655May 03 05:42 PM
LUCIER GREGORY TChairman & CEOMar 06Buy50.306,000301,800141,516Mar 08 05:58 PM
LUCIER GREGORY TChairman & CEOMar 01Buy48.576,000291,420135,516Mar 05 05:55 PM
Rosenberg Donald JDirectorFeb 12Option Exercise0.005,96305,963Feb 14 05:57 PM
Sylvain Jereme MChief Accounting OfficerFeb 01Option Exercise0.0093108,323Feb 05 05:59 PM
Carol CoxEVP External AffairsFeb 01Option Exercise0.001,929014,829Feb 05 05:58 PM
Link MatthewEVP, Strategy, Tech & Corp DevFeb 01Option Exercise0.002,660087,170Feb 05 05:55 PM
LUCIER GREGORY TChairman & CEOFeb 01Option Exercise0.0013,9980134,423Feb 05 05:54 PM
Link MatthewEVP, Strategy, Tech & Corp DevDec 27Option Exercise38.787,500290,85089,835Dec 29 05:57 PM
LUCIER GREGORY TChairman & CEOAug 29Buy61.522,000123,040120,425Aug 29 04:58 PM
HOWE LESLEY HDirectorAug 18Sale64.643,970256,62110,997Aug 18 04:11 PM
HOWE LESLEY HDirectorAug 17Option Exercise31.466,000188,76017,830Aug 18 04:11 PM
LUCIER GREGORY TChairman & CEOAug 17Buy66.225,000331,100118,245Aug 18 04:13 PM
Leddy Peter MichaelEVP Global HRAug 01Option Exercise0.002,265014,601Aug 03 05:58 PM
Carol CoxEVP External AffairsAug 01Option Exercise0.004,465014,577Aug 03 05:56 PM
Leddy Peter MichaelEVP Global HRAug 01Buy63.887,850501,48712,336Aug 03 05:58 PM
Sylvain Jereme MChief Accounting OfficerJul 01Option Exercise0.002,09108,177Jul 05 05:53 PM